Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Steroidogenic Activity in Unresected Adrenals Associated With Surgical Outcomes in Primary Aldosteronism

View through CrossRef
In patients with primary aldosteronism diagnosed with unilateral lesions through adrenal venous sampling, excess aldosterone occasionally persists after adrenalectomy. We investigated whether aldosterone values from unresected adrenals would be associated with postoperative outcomes. Overall, 102 primary aldosteronism patients, who underwent segmental adrenal venous sampling and unilateral adrenalectomy, were assessed for biochemical success (as outlined in the PASO [Primary Aldosteronism Surgical Outcomes] Study) at 1 year after surgery by using the saline infusion test. We divided patients into the biochemical complete or incomplete success group. Eighty-seven and 15 patients had complete and incomplete biochemical success, respectively. The biochemical incomplete group, compared with the biochemical complete group, had higher maximum aldosterone in tributary veins (11 000 versus 7030 pg/mL, P =0.006), maximum aldosterone/cortisol in tributary veins (18.05 versus 9.13, P <0.001), aldosterone in the central vein (9260 versus 5800 pg/mL, P =0.011), and aldosterone/cortisol in the central vein (13.67 versus 8.08, P <0.001) of the unresected adrenal gland. In logistic regression analyses, maximum aldosterone/cortisol in tributary veins had the highest area under the curve (0.780). Aldosterone/cortisol in the central vein had a nearly equivalent area under the curve (0.775). The lateralization index showed no significant differences between the groups. The clinical incomplete group similarly had higher aldosterone and aldosterone/cortisol in the unresected adrenal gland than did the clinical complete group. Therefore, steroidogenic activity in unresected adrenals (eg, absolute aldosterone value and aldosterone/cortisol) were associated with surgical outcomes. Our results may aid clinicians in determining the surgical application for primary aldosteronism.
Title: Steroidogenic Activity in Unresected Adrenals Associated With Surgical Outcomes in Primary Aldosteronism
Description:
In patients with primary aldosteronism diagnosed with unilateral lesions through adrenal venous sampling, excess aldosterone occasionally persists after adrenalectomy.
We investigated whether aldosterone values from unresected adrenals would be associated with postoperative outcomes.
Overall, 102 primary aldosteronism patients, who underwent segmental adrenal venous sampling and unilateral adrenalectomy, were assessed for biochemical success (as outlined in the PASO [Primary Aldosteronism Surgical Outcomes] Study) at 1 year after surgery by using the saline infusion test.
We divided patients into the biochemical complete or incomplete success group.
Eighty-seven and 15 patients had complete and incomplete biochemical success, respectively.
The biochemical incomplete group, compared with the biochemical complete group, had higher maximum aldosterone in tributary veins (11 000 versus 7030 pg/mL, P =0.
006), maximum aldosterone/cortisol in tributary veins (18.
05 versus 9.
13, P <0.
001), aldosterone in the central vein (9260 versus 5800 pg/mL, P =0.
011), and aldosterone/cortisol in the central vein (13.
67 versus 8.
08, P <0.
001) of the unresected adrenal gland.
In logistic regression analyses, maximum aldosterone/cortisol in tributary veins had the highest area under the curve (0.
780).
Aldosterone/cortisol in the central vein had a nearly equivalent area under the curve (0.
775).
The lateralization index showed no significant differences between the groups.
The clinical incomplete group similarly had higher aldosterone and aldosterone/cortisol in the unresected adrenal gland than did the clinical complete group.
Therefore, steroidogenic activity in unresected adrenals (eg, absolute aldosterone value and aldosterone/cortisol) were associated with surgical outcomes.
Our results may aid clinicians in determining the surgical application for primary aldosteronism.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Primary aldosteronism in the primary care setting
Primary aldosteronism in the primary care setting
Purpose of review The aim of the present manuscript is to provide an overview of the most updated studies on the prevalence of primary aldosteronism in primary care and...
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Abstract Epidemiologic studiessuggested the association between prenatal Di-(2-ethylhexyl) phthalate (DEHP) exposure and disorders of sex development (DSD), adult male diso...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
CLINICAL CHARACTERISES OF 224 CASES WITH NORMOKALEMIC AND HYPERTENSIVE PRIMARY ALDOSTERONISM
CLINICAL CHARACTERISES OF 224 CASES WITH NORMOKALEMIC AND HYPERTENSIVE PRIMARY ALDOSTERONISM
Objectives To investigate the clinical characteristics of patients with normokalemic and hypertensive primary aldosteronism. ...
Adrenocortical hypofunction with simultaneous primary aldosteronism
Adrenocortical hypofunction with simultaneous primary aldosteronism
Abstract Rationale: Cases of adrenocortical hyperfunction combined with primary aldosteronism have been reported in the literature, and the under...
Steroidogenic Factor-1 Controls the Aldose Reductase akr1b7 Gene Promoter in Transgenic Mice through an Atypical Binding Site
Steroidogenic Factor-1 Controls the Aldose Reductase akr1b7 Gene Promoter in Transgenic Mice through an Atypical Binding Site
Aldo-keto-reductase 1B7/mouse vas deferens protein (AKR1B7/MVDP) is expressed in rodent steroidogenic glands and in the mouse vas deferens. In steroidogenic organs, AKR1B7/MVDP sca...

Back to Top